Danielle Emille Mor

Assistant Professor

Neuroscience and Regenerative Medicine

https://orcid.org/0000-0003-3851-5010

EmailDMOR@augusta.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Danielle Emille Mor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

2 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Finished

The role of branched chain amino acid metabolism in the regulation of lifespan and cognitive decline
Mor, D. E.
1/1/20 → 9/30/20
Project: Research project
Alpha synuclein oligomer toxicity and the pathogenic interaction with dopamine
Mor, D. E.
12/1/14 → 10/30/16
Project: Research project

221 Citations
6 h-Index
9 Article

Metformin rescues Parkinson’s disease phenotypes caused by hyperactive mitochondria
Mor, D. E., Sohrabi, S., Kaletsky, R., Keyes, W., Tartici, A., Kalia, V., Miller, G. W. & Murphy, C. T., Oct 20 2020, In: Proceedings of the National Academy of Sciences. 117, 42, p. 26438-26447
Research output: Contribution to journal › Article › peer-review
Mitochondrial hyperactivity as a potential therapeutic target in Parkinson's disease.
Mor, D. E. & Murphy, C. T., Aug 12 2020, In: Translational Medicine of Aging. 4, p. 117-120
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration.
Mor, D. E., Daniels, M. & Ischiropoulos, H., Jan 11 2019, In: Movement disorders : official journal of the Movement Disorder Society. 34, 2, p. 167-179
Research output: Contribution to journal › Article › peer-review
20 Scopus citations
An integrative tissue-network approach to identify and test human disease genes.
Yao, V., Kaletsky, R., Keyes, W., Mor, D. E., Wong, A. K., Sohrabi, S., Murphy, C. T. & Troyanskaya, O., Oct 22 2018, In: Nature Biotechnology.
Research output: Contribution to journal › Article › peer-review
8 Scopus citations
The Convergence of Dopamine and α-Synuclein: Implications for Parkinson's Disease.
Mor, D. E. & Ischiropoulos, H., Mar 8 2018, In: Journal of Experimental Neuroscience.
Research output: Contribution to journal › Article › peer-review
6 Scopus citations

The role of branched chain amino acid metabolism in the regulation of lifespan and cognitive decline

Alpha synuclein oligomer toxicity and the pathogenic interaction with dopamine

Metformin rescues Parkinson’s disease phenotypes caused by hyperactive mitochondria

Mitochondrial hyperactivity as a potential therapeutic target in Parkinson's disease.

The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration.

An integrative tissue-network approach to identify and test human disease genes.

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson's Disease.